Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Exchange Rate Effect readings, the most recent being $2000.0 for Q3 2023.

  • On a quarterly basis, Exchange Rate Effect changed N/A to $2000.0 in Q3 2023 year-over-year; TTM through Jun 2023 was -$2000.0, a 0.0% change, with the full-year FY2025 number at $48000.0, up 118.18% from a year prior.
  • Exchange Rate Effect hit $2000.0 in Q3 2023 for Elicio Therapeutics, up from -$81000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $233000.0 in Q1 2020 to a low of -$287000.0 in Q4 2020.
  • Median Exchange Rate Effect over the past 4 years was -$3000.0 (2021), compared with a mean of -$33923.1.
  • The widest YoY moves for Exchange Rate Effect: up 987.5% in 2022, down 2800.0% in 2022.
  • Elicio Therapeutics' Exchange Rate Effect stood at -$287000.0 in 2020, then skyrocketed by 104.88% to $14000.0 in 2021, then surged by 521.43% to $87000.0 in 2022, then crashed by 97.7% to $2000.0 in 2023.
  • The last three reported values for Exchange Rate Effect were $2000.0 (Q3 2023), -$81000.0 (Q2 2023), and $79000.0 (Q1 2023) per Business Quant data.